| 肺动脉高压与免疫 |
| |
| 引用本文： | 吴文娜,王良兴,陈少贤. 肺动脉高压与免疫[J]. 国外医学:内科学分册, 2009, 36(3): 179-182 |
| |
| 作者姓名： | 吴文娜 王良兴 陈少贤 |
| |
| 作者单位： | 温州医学院附属第一医院呼吸内科,浙江,温州,325000;温州医学院附属第一医院呼吸内科,浙江,温州,325000;温州医学院附属第一医院呼吸内科,浙江,温州,325000 |
| |
| 摘 要： | 肺动脉高压是临床上常见的疾病，其发病机制尚未完全清楚。免疫因素在肺动脉高压的发病机制中起重要作用。自身免疫紊乱、免疫细胞、免疫分子在其发生过程中起着重要作用，免疫抑制疗法为肺动脉高压治疗提供了新的途径。
|
| 关 键 词： | 肺动脉高压 免疫机制 免疫细胞 免疫分子 |
Pulmonary arterial hypertension and immunity |
| |
| WU Wen-na,WANG Liang-xing,CHEN Shao-xian. Pulmonary arterial hypertension and immunity[J]. Foreign Medical Sciences(Section of Internal Medicine), 2009, 36(3): 179-182 |
| |
| Authors: | WU Wen-na WANG Liang-xing CHEN Shao-xian |
| |
| Affiliation: | WU Wen-na,WANG Liang-xing,CHEN Shao-xian. Department of Respiratory,The First Affiliated Hospital,Wenzhou Medical College,Wenzhou 325000,China |
| |
| Abstract: | Pulmonary hypertension is a common disease, and its pathogenesis is not entirely clear. Immune factors play an important role in the pathogenesis of pulmonary hypertension. Autoimmune disorders, immune cells and immune molecules play an important role in the occurrence of pulmonary hypertension. The immunosuppressive therapy provides a new way for pulmonary hypertension treatment. |
| |
| Keywords: | Pulmonary arterial hypertension Immunologic mechanism Immune cell Immune molecules |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
